Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study.
Journal: BMJ open
Published: May 11, 2026
Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.
Journal: Schizophrenia research
Published: December 12, 2025
For those with schizophrenia, does cannabidiol make cannabis use safer?
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: July 31, 2025
The effect of methamphetamine and 3,4-methylenedioxymethamphetamine on peripheral endocannabinoid concentrations: a study in healthy adults.
Journal: Psychopharmacology
Published: April 01, 2025
MDMA for treatment of PTSD and neurorehabilitation in military populations.
Journal: NeuroRehabilitation
Published: September 27, 2024
MDMA modulates human sensorimotor cortical pathways during gentle touch.
Journal: Imaging neuroscience (Cambridge, Mass.)
Published: April 25, 2024
The 3,4-methylenedioxymethamphetamine enhances early visual processing for salient socio-emotional stimuli.
Journal: The European journal of neuroscience
Published: February 06, 2024
MDMA enhances positive affective responses to social feedback.
Journal: Journal of psychopharmacology (Oxford, England)
Published: January 27, 2024
Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy.
Journal: Biological psychiatry. Cognitive neuroscience and neuroimaging
Published: October 09, 2023
Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia.
Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia.
Journal: Schizophrenia bulletin
Published: June 26, 2023
Last Updated: 09/26/2026